Mirabegron: A new option in treating overactive bladder

Heidi Camus Turpen, Philippe E. Zimmern

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Antimuscarinic medications have long been the mainstay of drug treatment for overactive bladder. This article describes mirabegron, one of a new class of agents that relaxes the detrusor muscle directly via a beta3 adrenoceptor agonist. Mirabegron's efficacy on frequency, urgency, and urge incontinence was tested in several trials before its wide clinical introduction. However, caution is still needed as data are lacking on the drug's efficacy and safety in frail older adults and for long-term therapy.

Original languageEnglish (US)
Pages (from-to)16-18
Number of pages3
JournalJournal of the American Academy of Physician Assistants
Issue number11
StatePublished - 2015


  • Beta adrenoceptor agonist
  • Detrusor muscle
  • Incontinence
  • Mirabegron
  • Overactive bladder
  • Voiding frequency

ASJC Scopus subject areas

  • Nurse Assisting


Dive into the research topics of 'Mirabegron: A new option in treating overactive bladder'. Together they form a unique fingerprint.

Cite this